Sun Pharma to Acquire Organon in $11.75 Bn Landmark Deal
Sun Pharmaceutical Industries has announced the acquisition of Organon & Co in an all-cash deal valued at approximately $11.75 billion (Around INR 1,10,620 crores), including debt, marking the largest overseas acquisition by an Indian pharma company. The transaction aligns with Sun Pharma’s strategic shift toward higher-margin specialty segments such as dermatology, oncology, and obesity, amid margin pressures in the US […]